sulbactam has been researched along with Escherichia coli Infections in 37 studies
*Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (13.51) | 18.7374 |
1990's | 13 (35.14) | 18.2507 |
2000's | 7 (18.92) | 29.6817 |
2010's | 8 (21.62) | 24.3611 |
2020's | 4 (10.81) | 2.80 |
Authors | Studies |
---|---|
Crast, LB; Gottstein, WJ; Graham, RG; Haynes, UJ; McGregor, DN | 1 |
Bahrs, C; Bartonickova, L; Burgmann, H; Hagel, S; Paulussen, E; Pletz, MW; Schneider, L; Starzengruber, P; Tobudic, S | 1 |
Fu, L; Li, H; Li, X; Liu, J; Luo, S; Wan, Z; Wang, Y; Wu, X; Xie, X; Zhao, Z | 1 |
Busch, DH; Dommasch, M; Feihl, S; Heim, M; Lahmer, T; Lukas, M; Querbach, C; Rothe, K; Schmid, RM; Schneider, G; Schneider, J; Spinner, CD; Treiber, M; Wallnöfer, F; Waschulzik, B; Wurst, M; Zink, A | 1 |
Durkan, K; Tuncel, A; Yurt, F | 1 |
Ali, I; Shabbir, M | 1 |
Adam, T; Bachmann, F; Budde, K; Friedersdorff, F; Liefeldt, L; Slowinski, T; Waiser, J | 1 |
Chaudhary, M; Kumar, S; Payasi, A | 1 |
Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S | 1 |
Baba, A; Ito, Y; Kasuga, E; Kusakari, M; Miyosawa, Y; Saida, K; Shima, Y | 1 |
Araújo, MC; De Resende, EA; Lazo-Chica, JE; Miguel, CB; Nogueira, AP; Oliveira, CJ; Paulino, Tde P; Rodrigues, WF; Soares, Sde C; Ueira-Vieira, C | 1 |
Arenoso, HJ; Bantar, C; Berger, MA; Fernandez Canigia, L; Soutric, JL | 1 |
Adams-Haduch, JM; Doi, Y; Jones, M; Pasculle, AW; Paterson, DL; Qureshi, ZA; Shutt, KA; Sidjabat, HE; Tian, GB; Waltner-Toews, RI | 1 |
Gao, ZH; Li, SM; Shen, JH; Zhang, BY | 1 |
Arenoso, H; Casellas, JM; Cohen, HS; MacDougall, N; Soutric, J; Tomé, G; Visser, M | 1 |
Chaiworapongsa, T; Cutright, J; Espinoza, J; Fidel, P; Ghezzi, F; Gomez, R; Romero, R; Wolf, N | 1 |
Kacmaz, B; Sultan, N | 1 |
Brook, I | 2 |
Arden, WA; Barker, DE; Derbin, M; Gellin, G; Leader, G; Record, K; Schwartz, RW; Strodel, WE | 1 |
Galandiuk, S; Lamos, J; Montgomery, W; Polk, HC; Young, S | 1 |
Lister, PD; Sanders, CC | 1 |
Alós, JI; Gómez-Garcés, JL; Mateos, MV | 1 |
Chandrasekar, PH; Kruse, JA; Sluchak, JA | 1 |
Gibbs, RS; Heddleston, L; McDuffie, RS | 1 |
Carias, LL; Rice, LB; Shlaes, DM | 1 |
Albanna, SE; McHugh, TP; Stewart, NJ | 1 |
Kim, KH; Park, KW; Yim, CB | 1 |
Carmeli, Y; Gold, H; Harris, AD; Kaye, KS | 1 |
Centretto, CA; Davies, JK; Gibbs, RS; Leslie, KK; McDuffie, RS; Sherman, MP; Wolf, DM | 1 |
Bisson, G; Edelstein, PH; Fishman, NO; Lautenbach, E; Patel, JB | 1 |
Fournier, MA; Guerra-Romero, L; Kennedy, SL; Täuber, MG; Tureen, JH | 1 |
Blanton, SJ; Gibbs, RS; McDuffie, RS; Shikes, RH | 1 |
Buré, A; Carbon, C; Caron, F; Fantin, B; Mohler, J; Pangon, B; Philippon, A; Potel, G; Vallée, E; Vallois, JM | 1 |
Azimi, P; Dunphy, MG; Hamstra, S; Kulhanjian, J; Levernier, K; Petru, A; Rankin, M | 1 |
Beale, AS; Gisby, J | 1 |
Bollinger, M; Greenberg, RN; Kennedy, DJ; Reilly, PM; Weinandt, WJ | 1 |
2 trial(s) available for sulbactam and Escherichia coli Infections
Article | Year |
---|---|
Intravenous amoxicillin-sulbactam against Escherichia coli: optimizing the dose, component ratio and infusion time using a human pharmacodynamic model.
Topics: Adult; Amoxicillin; Blood Bactericidal Activity; Cross-Over Studies; Drug Combinations; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Single-Blind Method; Sulbactam; Time Factors | 2009 |
Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children.
Topics: Acinetobacter Infections; Adolescent; Ampicillin; Arthritis, Infectious; Ceftriaxone; Cellulitis; Child; Child, Preschool; Drug Therapy, Combination; Escherichia coli Infections; Female; Gonorrhea; Haemophilus Infections; Humans; Infant; Male; Osteomyelitis; Prospective Studies; Random Allocation; Staphylococcal Infections; Streptococcal Infections; Sulbactam | 1989 |
35 other study(ies) available for sulbactam and Escherichia coli Infections
Article | Year |
---|---|
Synthesis and beta-lactamase inhibitory properties of 2 beta-(chloromethyl)-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide.
Topics: Amoxicillin; Animals; beta-Lactamase Inhibitors; beta-Lactams; Chemical Phenomena; Chemistry; Clavulanic Acid; Escherichia coli Infections; Mice; Mice, Inbred ICR; Penicillanic Acid; Staphylococcal Infections; Staphylococcus aureus | 1981 |
Early treatment response to piperacillin/tazobactam in patients with bloodstream infections caused by non-ESBL ampicillin/sulbactam-resistant Escherichia coli: a binational cohort study.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cohort Studies; Escherichia coli; Escherichia coli Infections; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quinolones; Retrospective Studies; Sulbactam | 2023 |
In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli.
Topics: Acinetobacter baumannii; Administration, Intravenous; Animals; Anti-Bacterial Agents; Biofilms; Colistin; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Monte Carlo Method; Sulbactam; Treatment Outcome; Urinary Tract Infections | 2020 |
Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Antimicrobial Stewardship; Aspergillosis; Azithromycin; Bacterial Infections; Cohort Studies; Coinfection; COVID-19; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Germany; Humans; Klebsiella Infections; Linezolid; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Retrospective Studies; SARS-CoV-2; Staphylococcal Infections; Streptococcal Infections; Sulbactam; Vancomycin; Young Adult | 2021 |
In vitro evaluation of
Topics: Ampicillin; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Technetium; Tin Compounds | 2021 |
Antibiotics susceptibility patterns of uropathogenic E. coli with special reference to fluoroquinolones in different age and gender groups.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Imipenem; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Tazobactam; Urinary Tract Infections; Young Adult | 2017 |
Perioperative antibiotic prophylaxis in renal transplantation: a single-center comparison between two regimens and a brief survey among the Eurotransplant renal transplantation centers.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Escherichia coli Infections; Europe; Female; Floxacillin; Humans; Kidney Transplantation; Male; Middle Aged; Perioperative Care; Piperacillin; Postoperative Complications; Retrospective Studies; Sepsis; Sex Factors; Sulbactam; Surgical Wound Infection; Surveys and Questionnaires; Urinary Tract Infections | 2019 |
In vitro susceptibilities of clinical isolates of Escherichia coli and Klebsiella species to CSE1034 and other β-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Combinations; Drug Resistance, Bacterial; Edetic Acid; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Sulbactam | 2013 |
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
Ampicillin- and ampicillin/sulbactam-resistant Escherichia coli infection in a neonatal intensive care unit in Japan.
Topics: Age Factors; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Incidence; Infant, Newborn; Intensive Care Units, Neonatal; Japan; Male; Sulbactam | 2016 |
Antibiotic Resistance of Bacteria Involved in Urinary Infections in Brazil: A Cross-Sectional and Retrospective Study.
Topics: Ampicillin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Retrospective Studies; Sulbactam; Urinary Tract Infections | 2016 |
Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Risk Factors; Sequence Analysis, DNA; Sulbactam; Young Adult | 2011 |
[Protective effects of snake venom antimicrobial peptide OH-CATH on E. coli induced rabbit urinary tract infection models].
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Host-Pathogen Interactions; Male; Microscopy, Electron, Transmission; Molecular Sequence Data; Peptides; Rabbits; Snake Venoms; Sulbactam; Urinary Bladder; Urinary Tract Infections | 2013 |
Urine inhibitory titers against resistant Escherichia coli isolates after oral amoxicillin-sulbactam.
Topics: Administration, Oral; Adult; Amoxicillin; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Penicillins; Sulbactam; Urinary Tract Infections; Urine | 2003 |
The effect of antibiotic therapy on intrauterine infection-induced preterm parturition in rabbits.
Topics: Ampicillin; Animals; Body Temperature; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Female; Fetal Membranes, Premature Rupture; Injections, Intramuscular; Pregnancy; Pregnancy Complications, Infectious; Rabbits; Random Allocation; Sulbactam | 2003 |
In vitro susceptibilities of Escherichia coli and Klebsiella spp. to ampicillin-sulbactam and amoxicillin-clavulanic acid.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Colony Count, Microbial; Diffusion Chambers, Culture; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Sulbactam | 2007 |
Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefotetan; Cefoxitin; Cephamycins; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Penicillins; Peritoneal Diseases; Sulbactam | 1995 |
Effect of cardiogenic shock on pharmacokinetics and tissue distribution of ampicillin-sulbactam.
Topics: Ampicillin; Animals; Ascitic Fluid; Bacteria; Cardiac Output; Drug Therapy, Combination; Escherichia coli Infections; Female; Intestinal Mucosa; Liver; Lung; Lymph; Lymph Nodes; Mesentery; Portal System; Shock, Cardiogenic; Sulbactam; Swine; Tissue Distribution | 1994 |
Antibiotic penetration of experimental intra-abdominal abscesses.
Topics: Abdominal Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefoxitin; Ceftriaxone; Clindamycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Escherichia coli Infections; Hydrogen-Ion Concentration; Male; Mice; Microbial Sensitivity Tests; Spectinomycin; Sulbactam | 1995 |
Comparison of ampicillin-sulbactam regimens simulating 1.5- and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in mice.
Topics: Ampicillin; Animals; Bacteremia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Escherichia coli Infections; Male; Mice; Sulbactam | 1995 |
[Bacteremia by Escherichia coli resistant to amoxycillin/clavulanic acid, ampicillin/sulbactam and piperacillin/tazobactam].
Topics: Aged; Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Penicillanic Acid; Sulbactam; Tazobactam | 1994 |
Therapy with cefoperazone plus sulbactam against disseminated infection due to cefoperazone-resistant Pseudomonas aeruginosa and Escherichia coli in granulocytopenic mice.
Topics: Agranulocytosis; Animals; beta-Lactamases; Cefoperazone; Colony Count, Microbial; Cyclophosphamide; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 1993 |
A rabbit model for ascending infection in pregnancy: intervention with indomethacin and delayed ampicillin-sulbactam therapy.
Topics: Ampicillin; Animals; Chorioamnionitis; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Female; Indomethacin; Pregnancy; Pregnancy Complications, Infectious; Premedication; Rabbits; Sulbactam; Time Factors; Treatment Outcome; Uterine Cervical Diseases | 1993 |
Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model.
Topics: Abdomen; Abscess; Ampicillin; Animals; Cefoxitin; Colony Count, Microbial; Drug Therapy, Combination; Escherichia coli Infections; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Sulbactam | 1993 |
Bilateral emphysematous pyelonephritis.
Topics: Abscess; Ampicillin; Anti-Bacterial Agents; Diabetic Nephropathies; Drug Therapy, Combination; Emphysema; Escherichia coli Infections; Female; Humans; Infarction; Kidney; Middle Aged; Nephrectomy; Penicillins; Pyelonephritis; Sulbactam; Tomography, X-Ray Computed | 1998 |
Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Citrobacter; Clavulanic Acid; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli Infections; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Penicillanic Acid; Pseudomonas Infections; Sulbactam; Triazoles | 1998 |
Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patients.
Topics: Aged; Ampicillin; Ampicillin Resistance; Analysis of Variance; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Models, Theoretical; Penicillins; Risk Factors; Sex Factors; Sulbactam | 2000 |
Chronic intrauterine infection and inflammation in the preterm rabbit, despite antibiotic therapy.
Topics: Amniotic Fluid; Ampicillin; Animals; Chronic Disease; Drug Administration Schedule; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Fetal Death; Fetal Diseases; Fetus; Inflammation; Pregnancy; Pregnancy Complications, Infectious; Rabbits; Sulbactam; Treatment Failure; Uterine Diseases; Uterus | 2002 |
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carrier State; Case-Control Studies; Cefepime; Cephalosporins; Cross Infection; Drug Therapy, Combination; Drug Utilization Review; Escherichia coli Infections; Feces; Female; Formularies, Hospital as Topic; Gentamicins; Hospitals, Community; Hospitals, Urban; Humans; Infection Control; Klebsiella Infections; Length of Stay; Male; Middle Aged; Pennsylvania; Prevalence; Risk Factors; Sulbactam | 2002 |
Use of ampicillin-sulbactam for treatment of experimental meningitis caused by a beta-lactamase-producing strain of Escherichia coli K-1.
Topics: Ampicillin; Animals; beta-Lactamases; Ceftriaxone; Drug Therapy, Combination; Escherichia coli Infections; Injections, Intravenous; Meningitis, Bacterial; Microbial Sensitivity Tests; Rabbits; Sulbactam | 1991 |
A rabbit model for bacterially induced preterm pregnancy loss: intervention studies with ampicillin-sulbactam.
Topics: Ampicillin; Animals; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Female; Fetal Death; Injections, Intramuscular; Pregnancy; Pregnancy Complications, Infectious; Progesterone; Rabbits; Sulbactam; Time Factors | 1991 |
Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.
Topics: Animals; beta-Lactamase Inhibitors; Ceftriaxone; Drug Combinations; Endocarditis, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Microbial Sensitivity Tests; Netilmicin; Rabbits; Sulbactam | 1990 |
In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cefotetan; Cefoxitin; Ceftizoxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; Male; Mice; Skin Diseases; Sulbactam | 1989 |
Comparative efficacies of amoxicillin-clavulanic acid and ampicillin-sulbactam against experimental Bacteroides fragilis-Escherichia coli mixed infections.
Topics: Amoxicillin; Ampicillin; Animals; Bacteroides fragilis; Bacteroides Infections; Clavulanic Acids; Drug Combinations; Escherichia coli; Escherichia coli Infections; Female; Injections, Subcutaneous; Mice; Microbial Sensitivity Tests; Sulbactam | 1988 |
Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation; Cefoperazone; Drug Combinations; Drug Evaluation; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Sulbactam; Urinary Tract Infections | 1987 |